Differential cytotoxicity responses by dog and rat hepatocytes to phospholipogenic treatments

Journal of Toxicology

Volumn 2013, Issue , 2013, Pages

  Morelli, James K ^a   Ciaccio, Paul J ^b  

^a SANOFI   (France)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE ORANGE; BAFILOMYCIN A1; BENZAMIDE DERIVATIVE; FLUOXETINE; HYDROXYCHLOROQUINE; N[5 METHYL 8 (4 METHYLPIPERAZIN 1 YL)TETRALIN 2 YL] 4 MORPHOLINO BENZAMIDE; PHOSPHOLIPID; PHOSPHOLIPOGENIC AGENT; SEROTONIN 1B ANTAGONIST; TOXIC SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; EXPERIMENTAL DOG; FLUORESCENCE ANALYSIS; IC 50; IN VITRO STUDY; LIVER CELL; LIVER MITOCHONDRION; LIVER PROTECTION; LYSOSOME; LYSOSOME MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

CANIS FAMILIARIS; RATTUS;

EID: 84876558723     PISSN: 16878191     EISSN: 16878205     Source Type: Journal    
DOI: 10.1155/2013/956404     Document Type: Article

References (22)

1. Reasor M. J., Hastings K. L., Ulrich R. G., Drug-induced phospholipidosis: issues and future directions. Expert Opinion on Drug Safety 2006 5 4 567 583 2-s2.0-33749128073 10.1517/14740338.5.4.567 (Pubitemid 44468453)
2. Daniel W. A., Wójcikowski J., The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions. Toxicology and Applied Pharmacology 1999 158 2 115 124 2-s2.0-0344004865 10.1006/taap.1999.8688 (Pubitemid 29343434)
3. Daniel W. A., Wójcikowski J., Palucha A., Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping. British Journal of Pharmacology 2001 134 4 807 814 2-s2.0-0034748454 (Pubitemid 33016152)
4. Shacka J. J., Klocke B. J., Shibata M., Uchiyama Y., Datta G., Schmidt R. E., Roth K. A., Bafilomycin A1 inhibits chloroquine-induced death of cerebellar granule neurons. Molecular Pharmacology 2006 69 4 1125 1136 2-s2.0-33645100369 10.1124/mol.105.018408
5. Kornhuber J., Henkel A. W., Groemer T. W., Städtler S., Welzel O., Tripal P., Rotter A., Bleich S., Trapp S., Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system. Journal of Cellular Physiology 2010 224 1 152 164 2-s2.0-77952500473 10.1002/jcp.22112
6. Zheng N., Zhang X., Rosania G. R., Effect of phospholipidosis on the cellular pharmacokinetics of chloroquine. Journal of Pharmacology and Experimental Therapeutics 2011 336 3 661 671 2-s2.0-79951962784 10.1124/jpet.110.175679
7. Reasor M. J., Kacew S., Drug-induced phospholipidosis: are there functional consequences? Experimental Biology and Medicine 2001 226 9 825 830 2-s2.0-0035687129 (Pubitemid 34053231)
8. Cartwright M. E., Petruska J., Arezzo J., Frank D., Litwak M., Morrissey R. E., MacDonald J., Davis T. E., Phospholipidosis in neurons caused by posaconazole, without evidence for functional neurologic effects. Toxicologic Pathology 2009 37 7 902 910 2-s2.0-74949128978 10.1177/0192623309348521
9. Reasor M. J., Hastings K. L., Ulrich R. G., Drug-induced phospholipidosis: issues and future directions. Expert Opinion on Drug Safety 2006 5 4 567 583 2-s2.0-33749128073 10.1517/14740338.5.4.567 (Pubitemid 44468453)
10. Reasor M. J., McCloud C. M., Beard T. L., Ebert D. C., Kacew S., Gardner M. F., Aldern K. A., Hostetler K. Y., Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague-Dawley rats. Toxicology 1996 106 1-3 139 147 2-s2.0-0030025618 10.1016/0300-483X(95)03175-F (Pubitemid 26038283)
11. Willard J., FDA phospholipidosis working group preliminary results and developing opinions. Presented at the Society of Toxicology (STP) Continuing Education Course on drug-induced phospholipidosis, 2008
12. Tengstrand E. A., Miwa G. T., Hsieh F. Y., Bis(monoacylglycerol)phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicities. Expert Opinion on Drug Metabolism and Toxicology 2010 6 5 555 570 2-s2.0-77951288434 10.1517/17425251003601961
13. Bernstein P. R., Morelli J., Ciaccio P., Drug-induced phospholipidosis. Annual Reports in Medicinal Chemistry 2011 46 419 429
14. Barone L. R., Boyer S., Damewood J. R. Jr., Fikes J., Ciaccio P. J., Phospholipogenic pharmaceuticals are associated with a higher incidence of histological findings than nonphospholipogenic pharmaceuticals in preclinical toxicology studies. Journal of Toxicology 2012 2012 7 308594 10.1155/2012/308594
15. Stenfors C., Hallerbäck T., Larsson L. G., Wallsten C., Ross S. B., Pharmacology of a novel selective 5-hydroxytryptamine 1B receptor antagonist, AR-A000002. Naunyn-Schmiedeberg's Archives of Pharmacology 2004 369 3 330 337 2-s2.0-1642407941 10.1007/s00210-004-0866-0 (Pubitemid 38372939)
16. Bernstein P., Hill D., Nugiel D., Pierson E., Shenvi A., Jacobs R., Chroman compounds as 5-HT1B receptor antagonists, their preparation, pharmaceutical compositions, and use in therapy. PCT Int. Appl. WO 2007053095, 2007
17. Morelli J. K., Buehrle M., Pognan F., Barone L. R., Fieles W., Ciaccio P. J., Validation of an in vitro screen for phospholipidosis using a high-content biology platform. Cell Biology and Toxicology 2006 22 1 15 27 2-s2.0-32144439413 10.1007/s10565-006-0176-z (Pubitemid 43207806)
18. Boya P., Gonzalez-Polo R. A., Poncet D., Andreau K., Vieira H. L. A., Roumier T., Perfettini J. L., Kroemer G., Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 2003 22 25 3927 3936 2-s2.0-0038677510 10.1038/sj.onc.1206622 (Pubitemid 36819666)
19. Boya P., Andreau K., Poncet D., Zamzami N., Perfettini J. L., Metivier D., Ojcius D. M., Jäättelä M., Kroemer G., Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. Journal of Experimental Medicine 2003 197 10 1323 1334 2-s2.0-0038529617 10.1084/jem.20021952 (Pubitemid 36617779)
20. Butler D., Brown Q. B., Chin D. J., Batey L., Karim S., Mutneja M. S., Karanian D. A., Bahr B. A., Cellular responses to protein accumulation involve autophagy and lysosomal enzyme activation. Rejuvenation Research 2005 8 4 227 237 2-s2.0-29144467982 10.1089/rej.2005.8.227 (Pubitemid 41814344)
21. Bendiske J., Bahr B. A., Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis-An approach for slowing Alzheimer disease? Journal of Neuropathology and Experimental Neurology 2003 62 5 451 463 2-s2.0-0037989761 (Pubitemid 36560187)
22. Teplova V. V., Tonshin A. A., Grigoriev P. A., Saris N. E. L., Salkinoja-Salonen M. S., Bafilomycin A1 is a potassium ionophore that impairs mitochondrial functions. Journal of Bioenergetics and Biomembranes 2007 39 4 321 329 2-s2.0-35648957732 10.1007/s10863-007-9095-9 (Pubitemid 350029431)